Fundz

Who to call at Cardiff Oncology, and when

Fundz watches for the moments Cardiff Oncology starts buying, and tells you who to reach.

  • An alert the day Cardiff Oncology raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Cardiff Oncology, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Cardiff Oncology. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Cardiff Oncology Enters Settlement Agreement with Nerviano Medical Sciences

Sep 14, 2026

Contract Type

settlement_agreement

San DiegoBiotechnologyHealth CareScience And Engineering

Description

On September 14, 2026, Cardiff Oncology, Inc. and Nerviano Medical Sciences, S.r.l. resolved their litigation through a Confidential Settlement Agreement and Release. The dispute involved matters related to inventorship of certain patents and performance issues under an existing License Agreement

Quick answer

Cardiff Oncology Enters Settlement Agreement with Nerviano Medical Sciences (September 14, 2026). Cardiff Oncology is based in San Diego, California, United States.

What agreement did Cardiff Oncology announce on September 14, 2026?
On September 14, 2026, Cardiff Oncology, Inc. and Nerviano Medical Sciences, S.r.l. resolved their litigation through a Confidential Settlement Agreement and Release.
What does Cardiff Oncology do?
Cardiff Oncology is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers.
Where is Cardiff Oncology based?
Cardiff Oncology is based in San Diego, California, United States.
Which similar companies announced agreements around the same time?
IgniteData (October 15, 2026), NeOnc Technologies (October 16, 2026), Danaher (October 18, 2026) and Encare AB (October 18, 2026) also announced agreements within 45 days of Cardiff Oncology.

Source: Fundz verified event record.

Other recent agreements in Science And Engineering and Biotechnology

Contracts and agreements at companies in the same sectors within 45 days, from Fundz verified event records.

Company Information

Company

Cardiff Oncology

Location

11055 Flintkote Avenue

San Diego, California, United States

About

Cardiff Oncology is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers. The Company's lead asset is onvansertib, a PLK1 inhibitor being evaluated in combination with standard of care (SoC) therapeutics in clinical programs targeting indications such as RAS-mutated metastatic colorectal cancer (mCRC), as well as in ongoing and planned investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma (mPDAC), small cell lung cancer (SCLC) and triple negative breast cancer (TNBC). These programs and the Company's broader development strategy are designed to target tumor vulnerabilities in order to overcome treatment resistance and deliver superior clinical benefit compared to the SoC alone.

Related People

Roger
Likely contact at this company
••••••••@••••••••

See Roger's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Cardiff Oncology's next move

Learn about Strategic plan

Cardiff Oncology signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.